Inventor
AHN YOUNG GIL
KR25 patents
⚠️ This page may combine multiple inventors who share the name “AHN YOUNG GIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HANMI PHARM IND CO LTD
11 patentsUS7625926B2Dec 1, 2009
P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
HANMI PHARM IND CO LTD9 citations83
US11292786B2Apr 5, 2022
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
HANMI PHARM IND CO LTD4 citations71
US10870639B2Dec 22, 2020
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
HANMI PHARM IND CO LTD3 citations71
US10519141B2Dec 31, 2019
Pyrimidine compound and pharmaceutical use thereof
HANMI PHARM IND CO LTD3 citations71
US10280154B2May 7, 2019
Pyrimidine compound and pharmaceutical use thereof
HANMI PHARM IND CO LTD4 citations71
US9388165B2Jul 12, 2016
Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase
HANMI PHARM IND CO LTD6 citations71
US11492357B2Nov 8, 2022
Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinase
HANMI PHARM IND CO LTD0 citations62
US11649246B2May 16, 2023
Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof
HANMI PHARM IND CO LTD0 citations61
USRE47451EJun 25, 2019
Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases
HANMI PHARM IND CO LTD1 citations60
US9156852B2Oct 13, 2015
Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases
HANMI PHARM IND CO LTD3 citations60
US11254676B2Feb 22, 2022
Pyrazole derivative compound and use thereof
HANMI PHARM IND CO LTD0 citations50
HANMI PHARMACEUTICAL CO LTD
7 patentsUS11535629B2Dec 27, 2022
Dioxoloisoquinolinone derivatives and use thereof
HANMI PHARMACEUTICAL CO LTD2 citations68
US12433867B2Oct 7, 2025
Pharmaceutical composition comprising FLT3 inhibitor and hypomethylating agent for treating acute myeloid leukemia
HANMI PHARMACEUTICAL CO LTD0 citations61
US12325698B2Jun 10, 2025
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
HANMI PHARMACEUTICAL CO LTD0 citations61
US10696675B2Jun 30, 2020
Imidazopyridopyrimidine derivative compound and use thereof
HANMI PHARMACEUTICAL CO LTD1 citations59
US12350265B2Jul 8, 2025
Pharmaceutical composition for treating acute myeloid leukemia, containing FLT3 inhibitor and chemotherapeutic agents
HANMI PHARMACEUTICAL CO LTD0 citations50
US12344618B2Jul 1, 2025
Heterotricyclic derivative compound and use of same
HANMI PHARMACEUTICAL CO LTD0 citations49
US12479845B2Nov 25, 2025
Imidazopyridine derivative compounds and use of same
HANMI PHARMACEUTICAL CO LTD0 citations48